share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

輝瑞 | 4：持股變動聲明-高管 JOHNSON RADY A
美股sec公告 ·  07/01 13:18
Moomoo AI 已提取核心訊息
Rady A Johnson, Executive Vice President of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on June 28, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Johnson after the action. The transaction is part of the regular financial disclosures made by company executives in compliance with SEC regulations.
Rady A Johnson, Executive Vice President of Pfizer Inc. (PFE), was reported to have engaged in a transaction involving the company's stock on June 28, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Johnson after the action. The transaction is part of the regular financial disclosures made by company executives in compliance with SEC regulations.
據報道，輝瑞公司（PFE）的執行副總裁Rady A Johnson於2024年6月28日進行了一筆涉及該公司股票的交易。交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值，在公告中沒有披露。報告還未提供Johnson在操作後持有的股票數量。該交易是公司高管按照美國證券交易委員會規定進行的定期財務披露的一部分。
據報道，輝瑞公司（PFE）的執行副總裁Rady A Johnson於2024年6月28日進行了一筆涉及該公司股票的交易。交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值，在公告中沒有披露。報告還未提供Johnson在操作後持有的股票數量。該交易是公司高管按照美國證券交易委員會規定進行的定期財務披露的一部分。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息